Open AccessRationale for the use of xymedon in the complex therapy of patients with psoriasis
Author(s) -
L. A. Galiullina,
R. Kh. Khafiz’yanova,
V. I. Mordovtsev
Publication year - 2022
Publication title -
kazanskij medicinskij žurnal
Language(s) - English
Resource type - Journals
eISSN - 2587-9359
pISSN - 0368-4814
DOI - 10.17816/kazmj96294
Subject(s) - psoriasis , medicine , intensive care medicine , dermatology
The use of the new home-made drug ximedone in combined therapy of patients with psoriasis is justified. Its immunosimulating effect, normalizing influence on the immune status indices, the absence of side effects are shown making it possible to recommend ximedone for the treatment of patients of any age.